Showing results (2081-2090 of 2,494) with videos related to
Sort By:
Pageof 250
ACS Chemical Neuroscience|October 18, 2019
N-(7-(1H-Imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)benzamide, a New Kainate Receptor Selective Antagonist and Analgesic: Synthesis, X-ray Crystallography, Structure-Affinity Relationships, and in Vitro and in Vivo PharmacologyStine Møllerud, Rie B Hansen, Jakob Pallesen, et al.Genome Biology|April 27, 2019
African evolutionary history inferred from whole genome sequence data of 44 indigenous African populationsShaohua Fan, Derek E Kelly, Marcia H Beltrame, et al.Nature|November 5, 2025
Two residues reprogram immunity receptors for nitrogen-fixing symbiosisMagdalini Tsitsikli, Bine Simonsen, Thi-Bich Luu, et al.Genome Biology|October 11, 2019
Correction to: African evolutionary history inferred from whole genome sequence data of 44 indigenous African populationsShaohua Fan, Derek E Kelly, Marcia H Beltrame, et al.European Journal of Preventive Cardiology|May 26, 2021
Socioeconomic position and first-time major cardiovascular event in patients with type 2 diabetes: a Danish nationwide cohort studyAlexander C Falkentoft, Bochra Zareini, Julie Andersen, et al.Molecular Pharmacology|July 12, 2007
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptorsKevin Erreger, Matthew T Geballe, Anders Kristensen, et al.Heart (British Cardiac Society)|August 6, 2016
Cardiac rehabilitation increases physical capacity but not mental health after heart valve surgery: a randomised clinical trialKirstine L Sibilitz, Selina K Berg, Trine B Rasmussen, et al.The Journal of General Physiology|December 3, 2025
Novel binding mode for negative allosteric NMDA receptor modulatorsJames S Lotti, Jed T Syrenne, Avery J Benton, et al.The Journal of Physiology|July 10, 2021
Global REACH 2018: the adaptive phenotype to life with chronic mountain sickness and polycythaemiaAlexander B Hansen, Gilbert Moralez, Sachin B Amin, et al.BMJ Open|December 15, 2015
Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trialMathias Ried-Larsen, Robin Christensen, Katrine B Hansen, et al.Pageof 250